Inicio>>Signaling Pathways>> Others>>KHK-IN-1 hydrochloride (ketohexokinase inhibitor)

KHK-IN-1 hydrochloride (ketohexokinase inhibitor)

Catalog No.GC30135

El clorhidrato de KHK-IN-1 (inhibidor de la cetohexocinasa) es un potente inhibidor de la cetohexocinasa (KHK) con una IC50 de 12 nM, interactúa con Asp-27B en la región de unión al ATP de KHK.

Products are for research use only. Not for human use. We do not sell to patients.

KHK-IN-1 hydrochloride (ketohexokinase inhibitor) Chemical Structure

Cas No.: 1303470-48-5

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
357,00 $
Disponible
5mg
321,00 $
Disponible
10mg
556,00 $
Disponible
50mg
1.669,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

KHK-IN-1 Hcl is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM, interacts with Asp-27B in the ATP-binding region of KHK.

[1]. Maryanoff BE, et al. Pyrimidinopyrimidine inhibitors of ketohexokinase: exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket. Bioorg Med Chem Lett. 2012 Aug 15;22(16):5326-9. [2]. Maryanoff BE, et al. Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site. ACS Med Chem Lett. 2011 Apr 18;2(7):538-43.

Reseñas

Review for KHK-IN-1 hydrochloride (ketohexokinase inhibitor)

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for KHK-IN-1 hydrochloride (ketohexokinase inhibitor)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.